| Rank | Name | World Wide Sales (mm) | CAGR | ||||||||
| 2007 | 2006 | Brand | Generic | 2005 | 2006 | 2007 | 1 yr | 3 yr | Company(s) | ||
| 1 | 1 | Lipitor | Atorvastatin | $13,378 | $14,385 | $12,700 | -12% | -2% | Pfizer, Astellas Pharma | ||
| 2 | 3 | Plavix | Clopidogrel | $6,360 | $6,057 | $7,977 | 32% | 8% | BMS, Sanofi-Aventis | ||
| 3 | 2 | Advair | Fluticasone + Salmeterol | $5,394 | $6,129 | $7,004 | 14% | 9% | GSK | ||
| 4 | 7 | Enbrel | Etanercept | $3,503 | $4,379 | $5,375 | 23% | 15% | Amgen, Wyeth | ||
| 5 | 4 | Nexium | Esomeprazole | $4,560 | $5,182 | $5,216 | 1% | 5% | AstraZeneca | ||
| 6 | 9 | Diovan | Valsartan | $3,590 | $4,223 | $5,012 | 19% | 12% | Novartis | ||
| 7 | 6 | Remicade | Infliximab | $3,410 | $4,428 | $4,975 | 12% | 13% | J&J, Schering-Plough, Tanabe | ||
| 8 | 8 | Zyprexa | Olanzapine | $4,189 | $4,364 | $4,760 | 9% | 4% | Eli Lilly | ||
| 9 | 10 | Risperdal | Risperidone | $3,430 | $4,183 | $4,696 | 12% | 11% | J&J | ||
| 10 | 12 | Rituxan | Rituximab | $3,243 | $3,861 | $4,600 | 19% | 12% | Roche, Genentech, Biogen, Chugai | ||
| 11 | 15 | Singulair | Montelukast | $2,863 | $3,579 | $4,300 | 20% | 15% | Merck & Co. | ||
| 12 | 21 | Herceptin | Trastuzumab | $533 | $3,134 | $4,050 | 29% | 97% | Roche, Genentech, Chugai | ||
| 13 | 16 | Seroquel | Quetiapine | $2,741 | $3,560 | $4,027 | 13% | 14% | AstraZeneca, Astellas Pharma | ||
| 14 | 22 | Lovenox | Enoxaparin | $2,631 | $3,210 | $4,000 | 25% | 15% | Sanofi-Aventis | ||
| 15 | 13 | Effexor | Venlafaxine | $3,424 | $3,722 | $3,794 | 2% | 3% | Wyeth | ||
| 16 | 11 | Aranesp | Darbepoetin alfa | $3,050 | $4,121 | $3,614 | -12% | 6% | Amgen | ||
| 17 | 5 | Norvasc | Amlodipine | $4,720 | $4,866 | $3,510 | -28% | -9% | Pfizer | ||
| 18 | 36 | Avastin | Bevacizumab | $520 | $2,364 | $3,425 | 45% | 87% | Roche, Genentech | ||
| 19 | 19 | Cozaar | Losartan | $3,036 | $3,163 | $3,400 | 7% | 4% | Merck & Co. | ||
| 20 | 54 | Atacand | Candesartan | $2,456 | $2,889 | $3,222 | 12% | 9% | Takeda , AstraZeneca | ||
| 21 | 27 | AcipHex | Rabeprazole | $2,838 | $2,729 | $3,158 | 16% | 4% | Eisai, J&J | ||
| 22 | 41 | Lantus | Insulin analog | $1,319 | $2,093 | $3,110 | 49% | 33% | Sanofi-Aventis | ||
| 23 | 43 | Humira | Adalimumab | $1,104 | $2,044 | $3,064 | 50% | 41% | Abbott | ||
| 24 | 20 | Fosamax | Alendronate | $3,197 | $3,134 | $3,050 | -3% | -2% | Merck & Co. | ||
| 25 | 30 | Gleevec | Imatinib | $2,094 | $2,554 | $3,050 | 19% | 13% | Novartis | ||
| 26 | 29 | Lexapro | Escitalopram | $2,265 | $2,696 | $3,045 | 13% | 10% | Forest , H. Lundbeck | ||
| 27 | 28 | Neulasta | Filgrastim | $2,222 | $2,710 | $3,000 | 11% | 11% | Amgen | ||
| 28 | 24 | Actos | Pioglitazone | $2,160 | $2,880 | $2,900 | 1% | 10% | Takeda , Eli Lilly | ||
| 29 | 18 | Procrit | Erythropoietin | $3,307 | $3,180 | $2,885 | -9% | -4% | J&J | ||
| 30 | 37 | Taxotere | Docetaxel | $2,003 | $2,201 | $2,870 | 30% | 13% | Sanofi-Aventis | ||
| 31 | 17 | Prevacid | Lansoprazole | $3,322 | $3,425 | $2,868 | -16% | -5% | TAP , Takeda | ||
| 32 | 35 | Avapro | Irbesartan | $2,064 | $2,372 | $2,854 | 20% | 11% | Sanofi-Aventis, BMS | ||
| 33 | 47 | Vytorin | Ezetimibe+Simvastatin | $196 | $1,955 | $2,800 | 43% | 143% | Merck & Co., Schering-Plough | ||
| 34 | 42 | Crestor | Rosuvastatin | $799 | $2,049 | $2,769 | 35% | 51% | AstraZeneca, Shionogi | ||
| 35 | 33 | Epogen | Erythropoietin | $2,461 | $2,511 | $2,489 | -1% | 0% | Amgen | ||
| 36 | 55 | Spiriva | Tiotropium | $954 | $1,735 | $2,467 | 42% | 37% | BI | ||
| 37 | 45 | Topamax | Topiramate | $1,601 | $2,027 | $2,453 | 21% | 15% | J&J | ||
| 38 | 23 | Avandia | Rosiglitazone | $2,252 | $3,043 | $2,440 | -20% | 3% | GSK | ||
| 39 | 46 | Prevnar | vaccine | $1,373 | $1,961 | $2,439 | 24% | 21% | Wyeth | ||
| 40 | 48 | Zetia | Ezetimibe | $1,196 | $1,929 | $2,400 | 24% | 26% | Merck & Co., Schering-Plough | ||
| 41 | 38 | Eloxatin | Oxaliplatin | $1,957 | $2,127 | $2,330 | 10% | 6% | Sanofi-Aventis | ||
| 42 | 44 | Celebrex | Celecoxib | $1,672 | $2,039 | $2,300 | 13% | 11% | Pfizer | ||
| 43 | 34 | Zyrtec | Cetirizine | $2,163 | $2,377 | $2,277 | -4% | 2% | Pfizer, UCB, Daiichi Sankyo | ||
| 44 | 51 | Lamictal | Lamotrigine | $1,493 | $1,843 | $2,196 | 19% | 14% | GSK | ||
| 45 | 32 | Aricept | Donepezil | $1,914 | $2,519 | $2,175 | -14% | 4% | Eisai, Pfizer | ||
| 46 | 58 | Micardis | Telmisartan | $1,069 | $1,645 | $2,125 | 29% | 26% | BI, Astellas Pharma | ||
| 47 | 75 | Cymbalta | Duloxetine | $79 | $1,316 | $2,100 | 60% | 198% | Eli Lilly | ||
| 48 | 64 | Levaquin | Levofloxacin | $1,545 | $1,863 | $2,047 | 10% | 10% | J&J, Daiichi | ||
| 49 | 14 | Protonix | Pantoprazole | $3,476 | $3,621 | $1,987 | -45% | -17% | Wyeth, Altana, Solvay | ||
| 50 | 31 | Ambien | Zolpidem | $1,705 | $2,545 | $1,910 | -25% | 4% | Sanofi-Aventis | ||
| 51 | 66 | Prograf | Tacrolimus | $1,199 | $1,499 | $1,876 | 25% | 16% | Astellas Pharma | ||
| 52 | 56 | Avonex | Interferon beta-1a | $1,519 | $1,707 | $1,870 | 10% | 7% | Biogen | ||
| 53 | 63 | Valtrex | Valaciclovir | $1,188 | $1,563 | $1,870 | 20% | 16% | GSK | ||
| 54 | 61 | TriCor | Fenofibrate | $972 | $1,567 | $1,811 | 16% | 23% | Abbott , Solvay | ||
| 55 | 57 | Viagra | Sildenafil | $1,640 | $1,657 | $1,764 | 6% | 2% | Pfizer | ||
| 56 | 53 | Epogin | Erythropoietin | $1,795 | $1,778 | $1,750 | -2% | -1% | Roche, Chugai | ||
| 57 | 40 | Tamiflu | Oseltamivir | $650 | $2,096 | $1,739 | -17% | 39% | Roche, Chugai | ||
| 58 | 65 | Arimidex | Anastrozole | $1,086 | $1,508 | $1,730 | 15% | 17% | AstraZeneca | ||
| 59 | 26 | Copaxone | Glatiramer | $1,009 | $1,414 | $1,713 | 21% | 19% | Teva Industries, Sanofi-Aventis | ||
| 60 | 69 | Rebif | Interferon beta-1a | $1,249 | $1,452 | $1,670 | 15% | 10% | Serono | ||
| 61 | 50 | Abilify | Aripiprazole | $1,008 | $1,282 | $1,660 | 29% | 18% | Otsuka , BMS | ||
| 62 | 68 | Xalatan | Latanoprost | $1,366 | $1,453 | $1,604 | 10% | 6% | Pfizer | ||
| 63 | 71 | Gemzar | Gemcitabine | $1,338 | $1,408 | $1,590 | 13% | 6% | Eli Lilly | ||
| 64 | 88 | Truvada | Tenofovir + Emtricitabine | $(119) | $1,194 | $1,590 | 33% | -337% | Gilead Sciences | ||
| 65 | 60 | Lupron | Leuprolide | $1,563 | $1,810 | $1,582 | -13% | 0% | Takeda , TAP | ||
| 66 | 77 | Depakote | Valproate semisodium | $1,059 | $1,308 | $1,575 | 20% | 14% | Abbott | ||
| 67 | 89 | Symbicort | Budesonide + Formoterol | $971 | $1,184 | $1,575 | 33% | 18% | AstraZeneca | ||
| 68 | 78 | Humalog | Insulin analog | $1,196 | $1,300 | $1,470 | 13% | 7% | Eli Lilly | ||
| 69 | 80 | Pulmicort | Budesonide | $1,150 | $1,292 | $1,454 | 13% | 8% | AstraZeneca | ||
| 70 | 52 | Toprol | Metoprolol | $1,741 | $1,795 | $1,438 | -20% | -6% | AstraZeneca | ||
| 71 | 112 | Cialis | Tadalafil | $680 | $971 | $1,430 | 47% | 28% | Lilly, Lilly Icos | ||
| 72 | 82 | Betaseron | Interferon beta-1b | $1,071 | $1,245 | $1,409 | 13% | 10% | Schering AG | ||
| 73 | 92 | Flomax | Tamsulosin | $834 | $1,158 | $1,380 | 19% | 18% | BI | ||
| 74 | 76 | Imitrex | Sumatriptan | $1,262 | $1,315 | $1,371 | 4% | 3% | GSK | ||
| 75 | 90 | Pegasys | Peg-interferon alfa-2a | $1,112 | $1,171 | $1,370 | 17% | 7% | Roche, Chugai | ||
| 76 | 73 | Benicar | Olmesartan | $370 | $1,370 | $1,343 | -2% | 54% | Daiichi Sankyo, Forest | ||
| 77 | 98 | Erbitux | Cetuximab | $473 | $1,075 | $1,336 | 24% | 41% | BMS, Merck KGaA | ||
| 78 | 86 | Casodex | Bicalutamide | $1,122 | $1,206 | $1,335 | 11% | 6% | AstraZeneca | ||
| 79 | 81 | Zometa | Zoledronate | $1,219 | $1,283 | $1,300 | 1% | 2% | Novartis | ||
| 80 | 85 | Neupogen | Filgrastim | $1,213 | $1,213 | $1,277 | 5% | 2% | Amgen | ||
| 81 | 84 | Flovent | Fluticasone | $1,158 | $1,219 | $1,243 | 2% | 2% | GSK | ||
| 82 | 108 | Botox | Botulin toxin | $805 | $982 | $1,211 | 23% | 15% | Allergan | ||